Nowadays, the most frequently used biomarkers used to guide diagnostic and treatment decisions for breast cancer patients are hormone receptors (estrogen, progesterone, and HER2 receptor) and the proliferation marker Ki-67 assessed by immunohistochemical analysis. The gene discussed is NR4A1; the disease is breast carcinoma.